Evaluation of digital and laminar blood flow in horses given a low dose of endotoxin

American Journal of Veterinary Research

Volumn 59, Issue 2, 1998, Pages 192-196

  Ingle Fehr, J E ^a   Baxter, G M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ANIMAL; ARTICLE; BLOOD FLOW VELOCITY; DRUG EFFECT; ENDOTOXEMIA; FEMALE; FORELIMB; HEART RATE; HORSE; HORSE DISEASE; LASER DOPPLER FLOWMETRY; MALE; ORCHIECTOMY; PATHOPHYSIOLOGY; TOE; VASCULARIZATION;

ANIMALS; BLOOD FLOW VELOCITY; ENDOTOXEMIA; ENDOTOXINS; FEMALE; FORELIMB; HEART RATE; HORSE DISEASES; HORSES; LASER-DOPPLER FLOWMETRY; MALE; ORCHIECTOMY; TOES;

EID: 0031990499     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Yelle M. Clinicians guide to equine laminitis. Equine Vet J 1986;18:156-158.
2. Coffman JR, Johnson JH, Guffy MM, et al. Hoof circulation in equine laminitis. J Am Vet Med Assoc 1970;156:76-83.
3. Moore JN, Allen D. The pathophysiology of acute laminitis. Vet Med (Praha) 1996;Oct:936-939.
4. Baxter GM. Acute laminitis. Vet Clin North Am Equine Pract 1994;10:627-642.
5. Hunt RJ. The pathophysiology of acute laminitis. Compend Contin Educ Pract Vet 1991;13:1003-1010.
6. Moore JN, Allen D, Clark ES. Pathophysiology of equine laminitis. Vet Clin North Am Equine Pract 1989;5:67-71.
7. Hood DM, Stephens KA. Physiopathology of equine laminitis. Compend Contin Educ Pract Vet 1981;12:454-459.
8. Robinson NE, Scott JB, Dabney JM, et al. Digital vascular responses and permeability in equine alimentary laminitis. Am J Vet Res 1976;37:1171-1176.
9. Allen D Jr, Clark ES, Moore JN, et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 1990;51:1930-1934.
10. Trout DR, Hornof WJ, Linford RL, et al. Scintigraphic evaluation of the digital circulation during the development and the acute phases of equine laminitis. Equine Vet J 1990;22:416-421.
11. Baxter GM. Alterations of endothelium-dependent digital vascular responses in horses given low-dose endotoxin. Vet Surg 1995;24:87-96.
12. Hinckley KA, Fearn S, Howard BR, et al. Nitric oxide donors as treatment for grass induced acute laminitis in ponies. Equine Vet J 1996;28:17-28.
13. Baxter GM. Equine laminitis caused by distal displacement of the distal phalanx: 12 cases (1976-1985). J Am Vet Med Assoc 1986;189:326-329.
14. Shuster R, Traub-Dargatz J, Baxter G. Survey of diplomates of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons regarding clinical aspects and treatment of endotoxemia in horses. J Am Vet Med Assoc 1997; 210:87-92.
15. Garner HE, Coffman JR, Hahn AW, et al. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 1975; 36:441-444.
16. Sprouse RF, Garner HE, Green EM. Plasma endotoxin levels in horses subjected to carbohydrate induced laminitis. Equine Vet J 1987;19:25-28.
17. Hood DM. Endotoxemia as a direct cause of laminitis, in Proceedings. Am Assoc Equine Pract 1995;41:245-247.
18. Baxter GM, Laskey RE, Tackett RL, et al. In vitro reactivity of digital arteries and veins to vasoconstrictive mediators in healthy horses and in horses with early laminitis. Am J Vet Res 1989;50:508-517.
19. Parker JL, Myers PR, Zhong Q, et al. Inhibition of endothelium-dependent vasodilation by Escherichia coli endotoxemia. Shock 1994;2:451-458.
20. Myers PR, Wright TF, Tanner MA, et al. Endothelial-derived relaxing factor and nitric oxide production in cultured endothelial cells: direct inhibition by E coli endotoxin. Am J Physiol 1992; 262:H710-H718.
21. Manning TO, Monteiro-Riviere NA, Bristol DG, et al. Cutaneous laser-Doppler velocimetry in nine animal species. Am J Vet Res 1991;52:1960-1964.
22. Hunt RJ, Brandon CI, McCann ME. Effects of acetylpromazine, xylazine, and vertical load on digital arterial blood flow in horses. Am J Vet Res 1994;55:375-378.
23. Adair HS III, Goble DO, Shires GMH, et al. Evaluation of laser doppler flowmetry for measuring coronary band and laminar microcirculatory blood flow in clinically normal horses. Am J Vet Res 1994;55:445-449.
24. Semrad SD, Hardee GE, Hardee MM, et al. Low dose flunixine meglumine: Effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Vet J 1987;19:201-206.
25. Bottoms GD, Fessier JF, Roesel OF, et al. Endotoxin-induced hemodynamic changes in ponies: effects of flunixin meglumine. Am J Vet Res 1981;42:1514-1518.
26. Galey FD, Twardock AR, Goetz TE, et al. Gamma scintigraphic analysis of the distribution of perfusion of blood in the equine foot during black walnut (Juglans nigra) induced laminitis. Am J Vet Res 1990;51:688-695.
27. Clark ES, Moore JN. The effects of slow infusion of a low dosage of endotoxin in healthy horses. Equine Vet J 1989;7:33-37.
28. Hunt RJ, Allen D, Moore JN. Effect of endotoxin administration on equine digital hemodynamics and Starling forces. Am J Vet Res 1990;51:1703-1707.
29. Clark ES, Collatos C. Hypoperfusion of the small intestine during slow infusion of low dosage of endotoxin in anesthetized horses. Cornell Vet 1990;80:163-172.
30. 2 antagonist in horses. Am J Vet Res 1993;54:586-590.
31. MacKay RJ, Merritt AM, Zertuche J-M, et al. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am J Vet Res 1991;52:533-538.
32. Bertone JJ, Gossett KA, Shoemaker KE, et al. Effect of hypertonic vs isotonic saline solution on responses to sublethal Escherichia coli endotoxemia in horses. Am J Vet Res 1990;51:999-1007.
33. Lanthier T, Miller C, McDonell WN, et al. Use of laser Doppler flowmetry to determine blood flow in and viability of island axial pattern skin flaps in rabbits. Am J Vet Res 1990;51:1914-1921.
34. Baxter G. Effects of tumor necrosis factor on in vitro digital arterial responses in horses. Am J Vet Res 1994;55:551-555.
35. Ignarro LJ, Byrns RE, Buga GM, et al. Endothelium-derived relaxing factor from pulmonary artery and vein possess pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987;61:866-879.
36. Luscher TF, Haefeli WE. L-arginine in the clinical arena: tool or remedy? Circulation 1993;87:1746-1748.
37. Janssens SF, Shimouchi A, Quertermous T, et al. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992;267:14519-14522.